Outcomes
Selected engagements across intellectual property, investment, transactions, and regulatory strategy.
Featured engagement
Defended a 14-patent portfolio against a biosimilar challenge across three jurisdictions.
$890MPortfolio value protected
A biosimilar challenge to a 14-patent portfolio across three jurisdictions.
Defended the patent portfolio across the three jurisdictions.
$890M protected.
Further engagements
Select an engagement to explore the challenge, our role, and the outcome.
IP structuring for a gene therapy platform undertaking a Series C raise.
Structured the IP holding architecture with freedom-to-operate clearance.
$340M Series C raise.
A cross-border acquisition involving an EU surgical robotics business.
Led regulatory and intellectual property due diligence.
$1.2B transaction.
A companion diagnostic PMA supplement tied to breakthrough therapy designation.
Navigated the FDA PMA supplement process.
Companion diagnostic approval in 11 months.
Representative engagements. Details anonymised to preserve client confidentiality. Past outcomes do not guarantee a similar result in another matter.